New York-based direct-to-consumer diagnostic startup LetsGetChecked has raised a $30 million Series B round led by Leerink Transformation Partners (LTP) with participation from existing investors Optum Ventures and Qiming Venture Partners USA.
The new capital will be directed at growing the company’s at-home testing platform and boosting its manufacturing and distribution capabilities. The company offers an array of procedures including STD tests, fertility tests and screenings for conditions like colon cancer and Celiac disease.
When Investment Rhymes with Canada
Canada has a proud history of achievement in the areas of science and technology, and the field of biomanufacturing and life sciences is no exception.
Founded in 2014, LetsGetChecked has raised around $42 million in total from investors.
“LetsGetChecked is taking lab testing and personal health management to the home through tight coordination of existing certified reference labs and logistics platforms,” LTP Managing Partner Todd Cozzens said in a statement.
“This creates a convenient and seamless consumer health testing experience, allowing timely access to results, follow-up care and professional guidance.”
Customers can purchase test kits on the LetsGetChecked website, or through one of the one company’s retail partners which include CVS and Walmart. The kit is then shipped to consumers who are directed on how to take a sample and mail back the package.
At ViVE 2024, Panelists Share Prior Authorization Progress and Frustration in Payer Insights Program
At the Payer Insights sessions on Day 1 of ViVE 2024, a panel on prior authorization offered compelling insights from speakers who shared the positive developments in this area after years of mounting frustration. Speakers also shared challenges as they work with providers to figure out how policy developments and technology will work in practice.
From there, the kits are sent to a CLIA-certified lab for analysis and results are returned to one of the company’s physicians who are on hand to discuss results and help guide further treatment if necessary.
Patients can access their results through the company’s online dashboard and also receive a nurse call to discuss results. LetsGetChecked also allows users to link their connected device data to the dashboard which can inform risk assessments and scores for conditions related to cardiovascular health.
LetsGetChecked products are currently available in the United States, Canada and Europe.
LetsGetChecked CEO Peter Foley positions the company as part of the growing trend of consumer-oriented personalized health products.
“We’re undergoing a major shift in the healthcare industry with a greater focus on personalized care and accessibility. Our belief is that everyone should have access to routine screening in the home, along with the clinical support to act on the information as required,” Foley wrote in an email.
“Chronic disease states and other prevalent health issues are far more manageable if identified earlier, which is why diagnostics are such a vital component to improving clinical outcomes for consumers.”
LetsGetChecked is just one of a number of startups meant make medical testing more accessible and convenient by providing a wide range of wellness and health tests directly to consumers.
One notable competitor is EveryWell, which received $50 million from investors to help expand its retail partnerships. Earlier this year, Israeli smartphone urinalysis startup Healthy.io announced an $18 million financing round to help bring its technology to the U.S.
Other players in the space include Los Angeles-based STD testing startup MyLabBox, Thorne – which evolved from selling supplements to offering consumer medical tests – and consumer genomics testing companies like 23andMe and Helix.
Credit: Getty Images, pixelliebe
